Vendor profile
Sanofi Oy
FI- Awards
- 10
- Total awarded value
- €96,791,341
- Countries
- countries.FI
- Latest award
- Apr 22, 2026
- Expiring within 12 months
- 0
Award history
| Date | Buyer | Title | Category | Value | Country | Expires | Source |
|---|---|---|---|---|---|---|---|
| 04/22/2026 | Sansia Oy | Finland – Pharmaceutical products – Lääkkeiden erillishankinnat Itä-Suomen yhteistyöalueelle, syksy 2025 | — | €1.8M | FI | — | View on TED ↗ |
| 08/27/2025 | HUS Group, the joint authority for Helsinki and Uusimaa | Finland – Pharmaceutical products – Nirsevimabin (Beyfortus 50 mg ja 100 mg injektioneste, liuos, esitäytetty ruisku) hankinta RSV-kaudelle 2025-2026 | — | €10.5M | FI | 03/31/2026 | View on TED ↗ |
| 07/15/2025 | Ministry of Social Affairs and Health | Finland – Vaccines – Diphtheria, tetanus, pertussis and polio (DTaP + IPV) vaccine for children 2026-2027 (2028, 2029) | — | €3.5M | FI | — | View on TED ↗ |
| 04/02/2025 | Terveyden ja hyvinvoinnin laitos | Finland – Antithrombotic agents – Enoksapariininatrium 100 mg/ml (1 ml esitäytetty ruisku) | — | €2.0M | FI | — | View on TED ↗ |
| 03/20/2025 | Ministry of Social Affairs and Health | Finland – Vaccines – Diphtheria, Tetanus and Pertussis (acellurar component) Booster (dtap) Vaccine 2025 - 2027 (2027 - 2028 and 2028 - 2029) | — | €5.0M | FI | — | View on TED ↗ |
| 12/18/2024 | Pohjois-Pohjanmaan hyvinvointialue | Finland – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – Monoklonaaliset vasta-aineet ajalle 1.1.-31.12.2025 + optiovuosi 2026 | — | €28.0M | FI | — | View on TED ↗ |
| 08/27/2024 | HUS Group, the joint authority for Helsinki and Uusimaa | Finland – Pharmaceutical products – Nirsevimabin (Beyfortus 50 mg ja 100 mg injektioneste, liuos, esitäytetty ruisku) hankinta RSV-kaudelle 2024-2025 | — | €14.0M | FI | — | View on TED ↗ |
| 04/15/2024 | Finnish Institute for Health and Welfare | Finland – Vaccines – Inactivated polio vaccine (IPV) and Diphtheria-Tetanus-Pertussis vaccine (DTaP) / 2024-2025 | — | €1.0 | FI | — | View on TED ↗ |
| 03/08/2024 | Pohjois-Pohjanmaan hyvinvointialue | Finland – Pharmaceutical products – Lääkevalmisteet ja niihin rinnastettavat tuotteet täydentävä kilpailutus ajalle 1.3.-31.12.2024 + optiovuosi 2025 | — | €2.0M | FI | — | View on TED ↗ |
| 01/30/2024 | Pohjois-Pohjanmaan hyvinvointialue | Finland – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – Monoklonaaliset vasta-aineet ajalle 1.1-31.12.2024 + optiovuosi 2025 | — | €30.0M | FI | 12/31/2024 | View on TED ↗ |